Effect of peri-operative crystalloid fluid rate on circulating hyaluronan in healthy dogs: A pilot study
Effect of peri-operative crystalloid fluid rate on circulating hyaluronan in healthy dogs: A pilot study
复制标题
DOI:
10.1016/j.tvjl.2020.105578
复制
发表时间:
2021-01-01
影响因子:
2.2
通讯作者:
Jeffery, U.
中科院分区:
文献类型:
--
作者:
Beiseigel, M.;Simon, B. T.;Jeffery, U.
Hypervolemia can damage the endothelial glycocalyx, a key regulator of vascular permeability, coagulation and inflammation. A starting peri-operative crystalloid fluid rate of 5 mL/kg/h is recommended for healthy dogs undergoing elective procedures but higher rates continue to be commonly used. This study aimed to determine if a higher starting perioperative fluid rate was associated with a greater increase in plasma concentrations of hyaluronan, a marker correlated with glycocalyx damage, in systemically healthy dogs undergoing elective surgical procedures.Based on a sample size calculation, 38 dogs undergoing ovariohysterectomy or castration were randomly assigned to receive lactated Ringer's at a starting perioperative fluid rate of 10 mL/kg/h (n = 19) or 5 mL/kg/h (n = 19). Plasma hyaluronan concentrations were measured by ELISA in pre- and post-fluid therapy samples. There were no significant differences between groups in hyaluronan values before (baseline, P= 0.52) or after perioperative fluid administration (P= 0.62). Compared to respective baseline values, hyaluronan values significantly increased following 5 and 10 ml/kg/h fluid administration (P=0.02 for both comparisons). This preliminary study identified an increase in hyaluronan over the course of fluid therapy with both the low and high fluid rate. One possible explanation is that both fluid rates contribute to glycocalyx disruption, but it should be emphasized that hyaluronan is not specific to the glycocalyx. Further studies are needed to determine the origin of the increased circulating hyaluronan and its clinical significance in dogs undergoing elective surgical procedures. (C) 2020 Elsevier Ltd. All rights reserved.